The interaction of a high-molecular-weight salivary glycoprotein (agglutinin) with Streptococcus sanguis M5 leads to the formation of bacterial aggregates. We have previously shown that the SSP-5 surface antigen from S. sanguis M5 binds the salivary agglutinin and therefore may be involved in the aggregation process. Here we report the transformation of a nonaggregating Enterococcusfaecalis strain with the SSP-5 gene and show that the protein is expressed on the cell surface and confers an aggregation-positive phenotype. E. faecalis S161 protoplasts were transformed with pAM401 EB-5, a shuttle vector containing the S. sanguis SSP-5 gene, resulting in the isolation of E. faecalis S161EB-5. Crude cell extracts from this transformant and from S. sanguis M5 were analyzed by Western blotting. Extracts from S. sanguis M5 possessed peptides of 190 and 205 kilodaltons that reacted strongly with polyclonal antibodies against the recombinant SSP-5 antigen. E. faecalis S161EB-5 contained only the 190-kilodalton immunoreactive protein, suggesting that the antigen may be processed differently in E. faecalis S161EB-5. The parent strain, E. faecalis S161, did not react with this antibody preparation. Immunogold labeling of intact E. faecalis S161EB-5 and S. sanguis M5 with anti-SSP-5 immunoglobulin G showed that both organisms expressed similar levels of the antigen. Both organisms formed visible aggregates upon incubation with salivary agglutinin. These results suggest that the SSP-5 antigen may mediate both the binding of agglutinin to S. sanguis M5 and the subsequent formation of bacterial aggregates.
Human saliva contains a high-molecular-weight glycoprotein (agglutinin) that binds to specific streptococci in a calcium-dependent reaction leading to the formation of bacterial aggregates (3, 4, 7, 14, 15, 21) . This reaction may represent one mechanism for modulating the attachment of oral streptococci to the salivary pellicle coating the tooth surface (16) . The agglutinin has been isolated and characterized (4, 14, 15) and appears to interact with the bacterial cell surface via carbohydrate moieties. Binding of salivary agglutinin to the bacterial surface can take place at 0°C, but formation of aggregates only occurs at physiological temperatures, suggesting that agglutinin-mediated aggregation may follow a multistep mechanism (15) . Calcium is required for binding of agglutinin; other divalent cations function inefficiently or are totally ineffective (15, 21) .
The oral streptococci vary greatly in the extent to which they are susceptible to agglutinin-mediated aggregation (14, 21) . However, it is not known if this variation is a function of receptor density, agglutinin binding specificity, multiple agglutinin receptors, or differences in the ability to form aggregates subsequent to binding the salivary molecule. It is also possible that distinct bacterial proteins are required for the agglutinin binding and aggregation reactions.
A number of streptococcal cell surface proteins have been implicated in the saliva-mediated aggregation of Streptococcus sanguis strains. Several studies have shown that sialic acid residues contained on salivary glycoproteins are involved in interactions with S. sangguis (12, 18) . Murray et al. have isolated a lectin specific for the N-acetylneuraminic acid-2,3-galactose-,B-1,3-N-acetylgalactose trisaccharide from Streptococcus mitis KS32AR (20) . This lectin was suggested to interact with MG2, a salivary mucin possessing * Corresponding author. aggregating activity (13 (9) . We have cloned the gene encoding a 205-kDa antigen (SSP-5) from S. sanguis M5 (2). This protein binds salivary agglutinin in vitro and competes with intact S. sanguis M5 for soluble agglutinin (2) . However, it was not clear if the presence of this protein alone was sufficient for aggregation to occur.
In the present study, we introduced the gene encoding the SSP-5 antigen from S. sanguis M5 into a nonaggregating strain of Enterococcus faecalis. The gene is efficiently expressed by the transformed organism, and the antigen is translocated to the cell surface. The transformed E. faecalis binds salivary agglutinin and aggregates in solutions containing parotid saliva or purified agglutinin. These results suggest that the SSP-5 antigen is sufficient for both the agglutinin binding and aggregation reactions of S. sanguis M5.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains used in this study are summarized in Table 1 . S. sanguis M5 and E. faecalis S161 (kindly supplied by B. Rosan) were grown overnight in brain heart infusion at 37°C. E. faecalis S161 used for transformation experiments was grown in Todd-Hewitt broth supplemented with 0.5 M sodium succinate (Sigma Chemical Co.) and 0.1 mg of bovine serum albumin per ml as described by Wirth et al. (23) . E. faecalis S161EB-5 was generated by transformation of E. faecalis S161 with pAM401EB-5 (see below) and was grown at 37°C in brain heart infusion supplemented with (6) . The transformed organism was designated E. coli DH-5(pAM401EB-5). Plasmid DNA was isolated from E. coli and E. faecalis strains by the method of Ish-Horowicz and Burke (10) followed by isopycnic CsCl gradient centrifugation (17) . Plasmid preparations from the E. faecalis strains required higher concentrations of lysozyme (1 mg/ml). Restriction digestions were carried out according to the specifications of the manufacturer. Digests were electrophoresed in 0.8% agarose (Bethesda Research Laboratories) and blotted by the method of Southern (22) . Hybridizations were carried out at 50°C in a mixture containing 50% formamide, 6x SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate), lx Denhardt solution, 50 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) (pH 6.8), 5 mM EDTA, and 0.4 mg of salmon sperm DNA per ml.
Transformation of E. faecalis S161. The transformation of E. faecalis S161 was performed essentially as described by Wirth et al. (23) . Cells were grown to early log phase in 1 liter of Todd-Hewitt broth containing 2% glycine (found to be optimal for E. faecalis S161), centrifuged (3,000 x g, 10 min), and suspended in 20 ml of Todd-Hewitt broth containing 50% sterile glycerol. The suspension was stored at -70°C in 1-ml aliquots. Optimal time for lysozyme treatment was determined as described by Wirth et al. (23) and found to be 90 min. Protoplasts were generated and transformed with pAM401EB-5 as previously described (23) . Trahsformed protoplasts gave rise to colonies after 1 to 2 days of incubation at 37°C on Todd-Hewitt agar plates containing 0.5 M sodium succinate, 0.1 mg of bovine serum albumin per ml, and 10 ,ug of chloramphenicol (Sigma) per ml.
Coloinies were transferred onto nitrocellulose, lysed by exposure to chloroform vapor for 15 min (8), and shaken overnight in lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 5 mM MgCI2, 40 ,ug of lysozyme per ml, 1 ,ug of DNase per ml, 3% bovine serum albumin). Filters were washed twice with PBS (10 mM sodium phosphate, pH 7.2, 150 mM NaCl) and reacted for 2 h with anti-SSP-5 serum or with polyclonal antibodies against P1 antigen from Streptococcus mutans (provided by K. Knox). Filters were washed with PBS and treated with peroxidase-conjugated anti-rabbit IgG (Fisher Scientific Co.) for an additional 2 h. Diaminobenzidine (0.5 mg/mIl in 50 mM Tris, pH 7.5, 0.03% H202) was added and shaken until sufficient color had developed. Positive colonies were designated E. faecalis S161EB-5.
Immunoblots and aggregation assays. Extracts-of S. sanguis M5, E. faecalis S161, and E. faecalis S161EB-5 were made by suspending 10 ml of an overnight culture in 0.5 ml of 0.5% sodium dodecyl sulfate (SDS) and boiling it for 5 min. Vertical 10% polyacrylamide slab gels were loaded with 25 ,ul of each extract, electrophoresed by the method of Laemmli (11) , and blotted by following published procedures (1) . Dot blots were spotted with approximately 2 x 107 cells prior to blocking in PBS containing 3% BSA. Reactions with primary and reporter antibodies were as described above. Filters were analyzed digitally as described by Demuth et Assays were conducted as described for the purification of salivary agglutinin.
Electron microscopy. Overnight cultures of E. faecalis S161, E. faecalis S161EB-5, and S. sanguis M5 were prepared for negative-staining electron immunocytochemistry. Cells were harvested by centrifugation (3,000 x g) for 10 min, washed three times with PBS, and suspended in PBS at approximately 1010 cells per ml.
Optimal concentrations of the various antisera utilized were established. Approximately 109 cells (0.1 ml) were mixed with an equal volume of mouse anti-SSP-5 IgG (0.1 mg/ml) and incubated at 37°C for 60 min. Cells were centrifuged (1,000 x g for 10 min), washed with PBS containing 0.5% bovine serum albumin, and suspended in PBS to the original volume. Reaction with goat anti-mouse IgG labeled with colloidal gold particles (20 nm) was carried out at 37°C for 60 min. The samples were centrifuged, washed as described above, and suspended in 0.1 ml of PBS. A drop of the bacterial suspensions was mixed with a drop of 0.5% phosphotungstic acid, and grids were blotted and evaluated in a Philips EM 300 electron microscope operated at 80 kV.
S. sanguis M5 incubated with rabbit anti-S. sanguis M5 sera as described above served as a positive control. Incubations of E. faecalis S161 with anti-SSP-5 sera and of E. faecalis S161EB-5 with preimmune mouse sera were used as negative controls. In addition, each organism was reacted with gold conjugate alone to monitor nonspecific binding of second antibody.
RESULTS
Transformation of E. faecalis S161. Growth conditions and protoplasting efficiency were optimized for E. faecalis S161 as described by Wirth et al. (23) . The addition of 2% glycine to the growth medium and treatment for 90 min with 1 mg of lysozyme per ml were found to be optimal for this strain. Approximately 500 transformed colonies were screened for the production of SSP-5 antigen as described in Materials and Methods. Virtually all of the colonies reacted with antibodies to intact S. sanguis M5 and polyclonal antibodies to the purified SSP-5 antigen. Antibodies against P1 antigen from S. mutans, which cross-react with the SSP-5 protein, also reacted strongly with these colonies. The transformed organism was designated E. faecalis S161EB-5.
To verify that the transformants contained pAM401EB-5, plasmid was isolated from E. faecalis S161EB-5 and digested with BamHI and EcoRI. This digest was compared with plasmid from E. coli DH-5(pAM401EB-5) digested by the same restriction enzymes. As shown in Fig. 1A from pAM401EB-5, indicating that no detectable deletions or rearrangements occurred after transformation of E. faecalis S161 protoplasts. Digests were also blotted and hybridized with the 5.3-kbp insert from plasmid pEB-5. Both digests contain a 5.3-kbp fragment that hybridized with this probe (Fig. 1B) .
Western (immuno-) blots of SDS extracts derived from E. faecalis S161EB-5, the parent strain E. faecalis S161, and S. sanguis M5 are shown in Fig. 2 . Blots were reacted with anti-SSP-5 serum. Extracts derived from E. faecalis S161EB-5 contained an immunoreactive peptide of approximately 190 kDa that was not present in extracts from the untransformed E. faecalis S161. This protein comigrated with a 190-kDa immunoreactive peptide from S. sanguis M5. Extracts of S. sanguis M5 contained immunoreactive proteins of approximately 205 and 190 kDa, consistent with previous results obtained with this organism (2) . Some degradation products were also observed.
Cellular location of expressed antigen. To determine whether the SSP-5 antigen expressed by E. faecalis S161EB-5 is localized on the cell surface, intact cells were spotted onto nitrocellulose and reacted with anti-SSP-5 serum. E.
faecalis S161 was included as a negative control; S. sanguis M5 served as a positive control. Spots containing S. sanguis M5 and E. faecalis S161EB-5 cells reacted strongly with antibodies to purified SSP-5 antigen (Fig. 3) . No reaction was observed with E. faecalis S161.
The cellular location and distribution of the expressed SSP-5 antigen were also determined by immunogold labeling of cells as described in Materials and Methods. S. sanguis M5, E. faecalis S161EB-5, and E. faecalis S161 were labeled with anti-SSP-5 IgG. S. sanguis M5 labeled with polyclonal antibodies raised against intact S. sanguis M5 served as a positive control. Anti-SSP-5 IgG labeled E. faecalis S161EB-5 and S. sanguis M5 to approximately the same extent, suggesting that these organisms express similar levels of SSP-5 antigen (Fig. 4A and B) . Labeling occurred over the entire cell, with a significant portion appearing at a distance VOL. 57, 1989 .i faecalis S161EB-S, and S. sanguis M5. Cells were diluted in PBS containing 30 ,ug of purified salivary agglutinin per ml to an optical density of approximately 1.4 and incubated at 37°C. Blank assays contained cells diluted in PBS without agglutinin. The blank assay for which results are shown contained E. faecalis S161EB-5 cells. Other blank assays that contained E. faecalis S161 and S. sanguis M5 (not shown) exhibited a total decrease in optical density of 0.08. from the cell surface, forming a halo around the cells. No reaction was observed with E. faecalis S161 (Fig. 4C) reacted with anti-SSP-5 IgG. S. sanguis M5 was heavily labeled by anti-S. sanguis M5 IgG, as shown in Fig. 4D . Labeling was evenly distributed, and as above, some labeling appeared at a distance from the cell surface. Preimmune mouse IgG did not react with any of the organisms tested (data not shown).
Agglutinin-mediated aggregation of E. faecalis S161EB-5. Intact S. sanguis M5 cells and purified SSP-5 antigen had previously been shown to bind salivary agglutinin in a calcium-dependent reaction (2) . To determine whether E. faecalis S161EB-5 could interact with salivary agglutinin and undergo agglutinin-mediated aggregation, cells were incubated with purified agglutinin by the method of Ericson et al. ( 3) The results are presented in Fig. 5 (15, 21) . This process occurs in two distinct steps (15) , (i) the calcium-dependent binding of agglutinin to the bacterial cell surface and (ii) the formation of bacterial aggregates. A surface antigen from S. sanguis M5, designated SSP-5, has been previously identified and shown to bind the salivary agglutinin (2) . However, that study did not conclusively show whether the SSP-5 antigen also mediated the subsequent formation of aggregates. Transformation of the gene encoding the SSP-5 antigen into E. faecalis S161, which does not aggregate in saliva, provides a system to determine the role of this protein in both the binding and aggregation reactions.
E. faecalis S161 protoplasts were transformed with the shuttle vector pAM401 carrying the SSP-5 gene with an efficiency of 3 x 104/,ug of DNA. This is comparable with previous transformations of other E. faecalis strains with this vector (23) . These cells expressed a protein of 190 kDa that reacted strongly with anti-SSP-5 IgG. The SSP-5 antigen of S. sanguis MS is extracted as two components of 205 and 190 kDa (2) . These results suggest that the SSP-5 antigen is processed differently after expression in E. faecalis S161. In support of this, plasmid pEB-5, which contains an insert identical to that of pAM401EB-5, directs the expression of three peptides (205, 190 , and 175 kDa) from the SSP-5 gene in E. coli DH-Sa (2). Thus, it appears likely that host factors play an important role in the processing or degradation of the SSP-5 antigen. The functional significance of this processing is not yet known.
The SSP-5 protein expressed by E. faecalis S161EB-5 was shown to be localized on the cell surface by immunoreactivity of intact cells with anti-SSP-5 and by immunogold labeling of transformants. Gold labeling experiments comparing E. faecalis S161EB-5 and S. sanguis M5 showed that (i) the SSP-5 antigen appears to be evenly distributed over the cell surface of both organisms, (ii) the levels of gold labeling observed on E. faecalis S161EB-5 and S. sanguis M5 are approximately equivalent, and (iii) at least a portion of the SSP-5 protein appeared at a distance from the surfaces of both S. sanguis M5 and E. faecalis S161EB-5. This may result from cell shrinkage during the fixation or staining procedures.
Alternatively, the SSP-5 protein may be associated with surface fibrils, as suggested by Hogg et al. (9) . Ganeshkumar et al. have observed a halo pattern of gold labeling with the SsaB adhesin and suggested the protein may be associated with short fibrils or the fuzzy coat of S. sanguis (5) . Although the pattern of labeling observed in these experiments is consistent with presence of surface fibrils or fimbriae, no such structures were obvious after negative staining of S. sanguis M5 or E. faecalis S161EB-5 with phosphotungstic acid. Thin-section labeling of these cells is currently being conducted to address this question.
Several aspects of the mechanism of agglutinin-mediated aggregation remain unclear. The SSP-5 antigen has been shown to bind salivary agglutinin in a calcium-dependent manner (2) , but the formation of aggregates may require additional factors or streptococcal proteins. The ability of E. faecalis S161EB-5 to undergo agglutinin-and saliva-mediated aggregation suggests that the SSP-5 protein mediates both the binding of salivary agglutinin to S. sanguis M5 and subsequent formation of bacterial aggregates. However, these results do not exclude the possibility that other surface proteins common to both E. faecalis S161 and S. sanguis M5 participate in SSP-5-mediated aggregation. Nor do they exclude the possibility that additional proteins of S. sanguis M5 function in a similar manner. Inactivation of the SSP-5 gene of S. sanguis M5 would begin to resolve this question.
